Tarlatamab-dlle: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

30 April 2025

  • curprev 11:1811:18, 30 April 2025 Parth Vikram Singh talk contribs 4,057 bytes +648 No edit summary
  • curprev 11:1011:10, 30 April 2025 Parth Vikram Singh talk contribs 3,409 bytes +3,409 Created page with "{{DrugProjectFormSinglePage |authorTag={{PVS}} |genericName=tarlatamab-dlle |aOrAn=a |drugClass=bispecific delta-like ligand 3 (DLL3)-directed CD3 T-cell engager bispecific delta-like ligand 3 (DLL3)-directed CD3 T-cell engager bispecific delta-like ligand 3 (DLL3)-directed CD3 T-cell engager bispecific delta-like ligand 3 (DLL3)-directed CD3 T-cell engager bispecific delta-like ligand 3 (DLL3)-directed CD3 T-cell engager bispecific delta-like ligand 3 (DLL3)-direct..."
Retrieved from "https://www.wikidoc.org/index.php/Tarlatamab-dlle"